Combination of PLX4720 and anti-PD-1/PD-L1 antibody improved the survival of the murine ATC model,243 and the combination of PLX4720 and oncolytic herpes simplex virus enhanced the anti-tumor effect with PD-1 blockade.244. Here, CD274 is linked to neoplasm.